InflaRx N.V. - Common Stock (IFRX)

InflaRx (NASDAQ:IFRX) outlined plans to prioritize development of izicopan, an oral inhibitor of the C5a receptor (C5aR), in ANCA-associated vasculitis (AAV) and other renal diseases during a company conference call led by CEO and founder Niels Riedemann. Izicopan positioned as a next-generation C5

Let's have a look at what is happening on the US markets after the closing bell on Friday. Below you can find the top gainers and losers in today's after hours session.

Volume analysis on 2025-11-12: stocks with an unusual volume in today's session.

Discover the stocks with unexpected trading volume in today's session on the US markets.

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Monday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.

The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.

Biogen gains exclusive rights to Vanqua's oral C5aR1 antagonist, boosting its immunology pipeline with potential across multiple immune diseases.

Several biotech stocks are showing renewed strength over the past week, with their Momentum scores soaring in Benzinga's Edge Stock Rankings.

Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.

Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

Curious about what's happening in today's session? Check out the latest stock movements and price changes.